Mydecine Innovations Group Inc. (CSE:MYCO)

Canada flag Canada · Delayed Price · Currency is CAD
0.2000
-0.0950 (-32.20%)
Oct 29, 2025, 4:00 PM EDT
-32.20%
Market Cap408.87K
Revenue (ttm)n/a
Net Income (ttm)220.73K
Shares Outn/a
EPS (ttm)0.18
PE Ratio1.85
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume91,423
Average Volume13,403
Open0.2750
Previous Close0.2950
Day's Range0.2000 - 0.2750
52-Week Range0.1200 - 0.7500
Beta2.25
RSI40.90
Earnings DateOct 31, 2025

About CSE:MYCO

Mydecine Innovations Group Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. It also develops MYCO-005, MYCO-006, and MYCO-007 for MDMA and psilocybin analogs. The company has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. Mydecine Innovations... [Read more]

Sector Healthcare
Founded 2013
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol MYCO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.